347 related articles for article (PubMed ID: 35663831)
1. The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review.
Araji G; Maamari J; Ahmad FA; Zareef R; Chaftari P; Yeung SJ
J Immunother Precis Oncol; 2022 Feb; 5(1):13-25. PubMed ID: 35663831
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota and Immune Checkpoint Inhibitors-Based Immunotherapy.
Tian M; Zhang S; Tseng Y; Shen X; Dong L; Xue R
Anticancer Agents Med Chem; 2022; 22(7):1244-1256. PubMed ID: 34229597
[TBL] [Abstract][Full Text] [Related]
3. The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer.
Duttagupta S; Hakozaki T; Routy B; Messaoudene M
Curr Oncol; 2023 Oct; 30(11):9406-9427. PubMed ID: 37999101
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
5. Complex interactions between the microbiome and cancer immune therapy.
Schwartz DJ; Rebeck ON; Dantas G
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
[TBL] [Abstract][Full Text] [Related]
6. The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era.
Spyrou N; Vallianou N; Kadillari J; Dalamaga M
Semin Cancer Biol; 2021 Aug; 73():356-376. PubMed ID: 33989733
[TBL] [Abstract][Full Text] [Related]
7. Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review.
Huang C; Li M; Liu B; Zhu H; Dai Q; Fan X; Mehta K; Huang C; Neupane P; Wang F; Sun W; Umar S; Zhong C; Zhang J
Front Oncol; 2021; 11():642110. PubMed ID: 33816289
[No Abstract] [Full Text] [Related]
8. Cancer immunotherapy resistance: The impact of microbiome-derived short-chain fatty acids and other emerging metabolites.
Hersi F; Elgendy SM; Al Shamma SA; Altell RT; Sadiek O; Omar HA
Life Sci; 2022 Jul; 300():120573. PubMed ID: 35469916
[TBL] [Abstract][Full Text] [Related]
9. Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review.
Pierrard J; Seront E
Curr Oncol; 2019 Dec; 26(6):395-403. PubMed ID: 31896938
[TBL] [Abstract][Full Text] [Related]
10. The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer.
Naqash AR; Kihn-Alarcón AJ; Stavraka C; Kerrigan K; Maleki Vareki S; Pinato DJ; Puri S
Ann Transl Med; 2021 Jun; 9(12):1034. PubMed ID: 34277834
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and immunotherapy of renal cell carcinoma.
Bibbò S; Porcari S; Del Vecchio LE; Severino A; Mullish BH; Ianiro G; Gasbarrini A; Cammarota G
Hum Vaccin Immunother; 2023 Dec; 19(3):2268982. PubMed ID: 37955340
[TBL] [Abstract][Full Text] [Related]
12. Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.
Renga G; Nunzi E; Pariano M; Puccetti M; Bellet MM; Pieraccini G; D'Onofrio F; Santarelli I; Stincardini C; Aversa F; Riuzzi F; Antognelli C; Gargaro M; Bereshchenko O; Ricci M; Giovagnoli S; Romani L; Costantini C
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35236743
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
14. The role of gut microbiome in immune modulation in metastatic renal cell carcinoma.
Deluce J; Maleki Vareki S; Fernandes R
Ther Adv Med Oncol; 2022; 14():17588359221122714. PubMed ID: 36105887
[TBL] [Abstract][Full Text] [Related]
15. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications.
Lee KA; Shaw HM; Bataille V; Nathan P; Spector TD
Eur J Cancer; 2020 Oct; 138():149-155. PubMed ID: 32889369
[TBL] [Abstract][Full Text] [Related]
16. The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Oh B; Boyle F; Pavlakis N; Clarke S; Eade T; Hruby G; Lamoury G; Carroll S; Morgia M; Kneebone A; Stevens M; Liu W; Corless B; Molloy M; Kong B; Libermann T; Rosenthal D; Back M
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638308
[No Abstract] [Full Text] [Related]
17. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
18. The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer.
Katayama Y; Yamada T; Shimamoto T; Iwasaku M; Kaneko Y; Uchino J; Takayama K
Transl Lung Cancer Res; 2019 Dec; 8(6):847-853. PubMed ID: 32010563
[TBL] [Abstract][Full Text] [Related]
19. The role of the sex hormone-gut microbiome axis in tumor immunotherapy.
Wang L; Tang L; Zhai D; Song M; Li W; Xu S; Jiang S; Meng H; Liang J; Wang Y; Zhang B
Gut Microbes; 2023; 15(1):2185035. PubMed ID: 36880651
[TBL] [Abstract][Full Text] [Related]
20. Microbiome bacterial influencers of host immunity and response to immunotherapy.
Yousefi Y; Baines KJ; Maleki Vareki S
Cell Rep Med; 2024 Apr; 5(4):101487. PubMed ID: 38547865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
